Innovate UK awards Sano Genetics £330,000 grant for ALS study
Posted:
Sano has been awarded a £330K grant from @InnovateUK to develop “Light The Way,” a platform for individuals at risk of genetic #ALS. Access to genetic testing, counselling, education, and peer support will be provided at no cost.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.